Volume 23 - Issue 7 - July 2015
Cover Story
07/16/2015
Today, a cosmetic patient’s goal often is to improve the appearance of the hands with the least downtime and as few treatments as possible. If one treatment could treat both the hyperpigmentation as well as improve the appearance of the...
Today, a cosmetic patient’s goal often is to improve the appearance of the hands with the least downtime and as few treatments as possible. If one treatment could treat both the hyperpigmentation as well as improve the appearance of the...
Today, a cosmetic patient’s goal...
07/16/2015
The Dermatologist
Column
Spotlight
07/16/2015
Dr. Schmults is the director of the Mohs and Dermatologic Surgery Center and High Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Cancer Center.
Dr. Schmults is the director of the Mohs and Dermatologic Surgery Center and High Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Cancer Center.
Dr. Schmults is the...
07/16/2015
The Dermatologist
Chief Medical Editor Message
07/16/2015
Just as the development of the first biologics raised questions on how they should be used, the introduction of biosimilars raises new questions.
Just as the development of the first biologics raised questions on how they should be used, the introduction of biosimilars raises new questions.
Just as the development of the...
07/16/2015
The Dermatologist
News
News
07/16/2015
The dermal filler calcium hydroxylapatite (Radiesse, Merz North America) received FDA approval for hand augmentation to correct volume loss in the dorsum of the hands. The dermal filler provides a volumizing effect that can last up to 1...
The dermal filler calcium hydroxylapatite (Radiesse, Merz North America) received FDA approval for hand augmentation to correct volume loss in the dorsum of the hands. The dermal filler provides a volumizing effect that can last up to 1...
The dermal filler calcium...
07/16/2015
The Dermatologist
